[1] |
高明,李小龙.当今国内甲状腺癌发展趋势之面对[J/CD].中华普通外科学文献:电子版, 2014, 8(1): 1-3.
|
[2] |
王菁,蒋天安,牟芸,等.超声引导下甲状腺钙化结节细针穿刺细胞学无法诊断率的分析[J].中华医学杂志, 2014, 94(37):2948-2950.
|
[3] |
Gupta M, Chia SY. Circulating thyroid cancer markers[J]. Curr Opin Endocrinol Diabetes Obes, 2007, 14(5): 383-388.
|
[4] |
Takano T. Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma[J]. Endocr, 2004, 51(6): 509-515.
|
[5] |
Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice[J]. Semin Cancer Biol, 2007,17(3): 233-240.
|
[6] |
Revekka G, Christina L, Ekaterini P, et al. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas[J]. Int J Gynecol Cancer, 2014,24(5):851-856.
|
[7] |
Grob F, Deladoy J, Legault L, et al. Autonomous adenomas caused by somatic mutations of the thyroid-stimulating hormone receptor in children[J]. Horm Res Paediatr, 2014, 81(2): 73-79.
|
[8] |
Hébrant A, van Staveren WC, Maenhaut C, et al. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations[J]. Eur J Endocrinol, 2011, 164(1): 1-9.
|
[9] |
Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing[J]. Cancer Res, 2003, 63(9): 2316-2321.
|
[10] |
戴亚丽,蔡德鸿,陈宏,等.乳头状甲状腺癌TSHR基因转录表达和启动子区甲基化研究[J].南方医科大学学报, 2010, 30(1):114-117.
|
[11] |
Matsumoto H, Sakamoto A, Fujiwara M, et al. Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid[J]. Oncol Rep, 2008,19(6):1405-1411.
|
[12] |
李清怀,张晓娟,李筱,等.促甲状腺激素受体在分化型甲状腺癌组织中的表达及意义[J].中华肿瘤杂志, 2013, 35(10):751-753.
|
[13] |
Ye J, Jia J, Dong S, et al. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis[J]. Eur J Cancer Prev, 2014, 23(3): 158-165.
|
[14] |
Giráldez MD, Lozano JJ, Ramírez G, et al. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study[J]. Clin Gastroenterol Hepatol, 2013, 11(6): 681-688.
|
[15] |
Wagner K, Arciaga R, Siperstein A, et al. Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: diagnostic synergy for detecting thyroid cancer[J]. J Clin Endocrinol Metab, 2005, 90(4): 1921-1924.
|
[16] |
Chia SY, Milas M, Reddy SK, et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the pre-operative diagnosis of thyroid cancer[J]. J Clin Endocrinol Metab, 2007, 92(2): 468-475.
|
[17] |
Milas M, Shin J, Gupta M, et al. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1 758 samples[J]. Ann Surg, 2010, 252(4): 643-651.
|
[18] |
Novosel T, Ritter HE, Gupta M, et al. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas[J]. Surgery, 2009, 146(6): 1081-1089.
|
[19] |
Berber E, Aliyev A, Dural AC, et al. The utility of thyrotropin receptor messenger RNA detection in patients with papillary thyroid microcarcinoma[J]. Sci Papers: 2014 Clin Congress, 2014, 219(4s): e11.
|
[20] |
Qiu J, Zhang Y, Guo X, et al. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma[J]. Neoplasma, 2010, 57(4): 360-364.
|
[21] |
Gutnick J, Soldes O, Gupta M, et al. Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children[J]. J Pediatr Surg, 2012, 47(1): 171-176.
|
[22] |
Milas M, Mazzaglia P, Chia SY, et al. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers[J]. Surgery, 2007, 141(2): 137-146.
|
[23] |
任婷婷,吴艺捷,金宇飚,等.外周血促甲状腺激素受体mRNA鉴别甲状腺良恶性结节的研究[J].中华内分泌代谢杂志, 2013,29(2): 112-115.
|
[24] |
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2009,19(11): 1167-1214.
|
[25] |
Chinnappa P, Taguba L, Arciaga R, et al. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts inperipheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer[J]. J Clin Endocrinol Metab, 2004, 89(8): 3705-3709.
|
[26] |
Milas M, Barbosa GF, Mitchell J, et al. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer[J]. Ann Surg Oncol, 2009, 16(2): 473-480.
|
[27] |
Torosian L, Manrique G, Alvarez B, et al. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients[J]. Rev Esp Med Nucl, 2010, 29(3): 109-113.
|